Navigation Links
Economic Conditions Signal Long-Term Shift in Rx Benefit Approach
Date:9/14/2009

on Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
2. McKesson Corporation CEO to Address the Detroit Economic Club on Preserving Our Healthcare System and Improving Quality of Life
3. Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development
4. AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. Economic motivation may affect how often some physicians order imaging studies
7. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
8. Through-Wave Ultrasound: Effective, Economical and Ideal for Breast Imaging, Biopsy
9. MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements
10. Skatepark injuries can incur economic pain
11. AARP Calls New EEOC Policy A Civil Rights and Economic Fiasco

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Not sure how to optimize your Emergency Depar...H1N1 influenza cases this season? Should you test...ould you use? Which - if any - antiviral should yo...09 issue of Emergency Medicine Practice, which pre...resources on influenza diagnosis and treatment. ,...
(Date:11/25/2009)... BenefitPackages.com, California,s designated ...to raise awareness during the November 15 - Decemb...lows them to enroll in a zero-cost PPO Medicare Ad...lue Cross are available through BenefitPackages.co... Calabasas, CA (PRWEB) November 25, 2009...
(Date:11/24/2009)...esidents generally provide accurate preliminary in...after hours when attending neuroradiologist unavai...rmed at a level I trauma center published in the D...ege of Radiology ( JACR ). , The accuracy of i...of diagnostic radiology. In most training programs...
(Date:11/24/2009)...rs from Boston University School of Medicine (BUSM... Department have identified a number of proteins w... cancer and normal cells with almost 97 percent ac...oped a new computational strategy to analyze this ...ways (molecular circuits) that are active in cance...
(Date:11/24/2009)...Nov.24/PRNewswire/--Quantros,aleadinghealthcareana...r,announcedtodaythatithaslicensedintellectualprope...MichiganforintegrationintoQuantros,suiteofsafetyan...sity,ssoftwarewithintheSRMproductfamilywillenablea...oughutilizationofahealthcareprovider,sintegratedad...
Breaking Medicine News(10 mins):Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 2Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 3Health News:BenefitPackages.com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2
...arning pharmaceutical manufacturers, suppliers, dr...d medications to be especially vigilant in assuri...ide in liquid over-the-counter and prescription dr... guidance to industry recommending methods of test...
...lkers in the world, as the speed at which the city...st decade. In a sample of 32 cities around...itizens of Copenhagen, Madrid and Guangzhou in Chi...ut walking fast is not good for you, according to ...
... to fight against cancer for the fifth time . ...iagnosed with cancer for the fifth time, started a...cerous nodules were discovered in his lungs. ...ever had but I have fought hard throughout my life...
...tates appears to be strongly associated with incre... study. Dr. Winchester and colleagues fou... and nitrates measurements in surface water were h... from 1996-2002. Preterm birth varied from a high ...
...e trauma abdomen and pelvis CT compared to plain r... by radiologists at the University of Cincinnati. ...derwent plain radiographs and abdomen and pelvis C...ccording to the study, 180 (19.3%) of the patients...
...y rankings of the fattest cities, the fittest citi... cities . Now, in the first-of-its-kind survey, th...he cities that take sun protection seriously and t...s spanning 29 states on their knowledge, attitudes...
Other Medicine News:Health News:FDA Advises Manufacturers to Test Glycerin for Possible Contamination 2Health News:Bobby Robson Diagnosed With Cancer for Fifth Time 2Health News:Premature Birth Linked With Increased Use of Pesticides 2Health News:New Survey List Out Cities That Take Sun Protection Seriously 2Health News:New Survey List Out Cities That Take Sun Protection Seriously 3
(Date:11/24/2009)....24/PRNewswire/--MAQUETCardiovascularLLC,aleadingp...thatithassignedaguaranteedtwo-yearcontractwithNova...ations,tobethesolesourceproviderofsurgicaldevicesf...ftheagreement,whichrunsthroughOctober31,2012,MAQUE...heartdevicesanddisposablesuppliestothemembersofVHA...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--Orexigen®Therapeutic...usedonthetreatmentofobesity,todayannouncedthatonNo...sBoardofDirectorsgrantedaninducementstockoptiontop...M.D.,itsnewlyappointedHeadoftheGlobalContraveProgr...tockoptiontotheextentpermittedbylawandhasanexercis...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--BioSpecificsTechnolo...developingfirstinclasscollagenase-basedproducts,to...illpresentattheupcomingPiperJaffray21stAnnualHealt...atTheNewYorkPalaceHotelinNewYork,NY. ,, Alivewe...fEvents"intheInvestorRelationssectionoftheCompany,...
Breaking Medicine Technology:MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Comic Strip Aims to Educate Families About Diabetes 50383 1New Data 3A Efficacy and Responder Analyses of Divigel 28R 29 28estradiol gel 29 0 1 percent for the Treatment of Menopause 50378 1New Data 3A Efficacy and Responder Analyses of Divigel 28R 29 28estradiol gel 29 0 1 percent for the Treatment of Menopause 50378 2New Data 3A Efficacy and Responder Analyses of Divigel 28R 29 28estradiol gel 29 0 1 percent for the Treatment of Menopause 50378 3New Data 3A Efficacy and Responder Analyses of Divigel 28R 29 28estradiol gel 29 0 1 percent for the Treatment of Menopause 50378 4New Data 3A Efficacy and Responder Analyses of Divigel 28R 29 28estradiol gel 29 0 1 percent for the Treatment of Menopause 50378 5Medifast Inc Added to the Russell 3000 Index 50375 1Medifast Inc Added to the Russell 3000 Index 50375 2Medifast Inc Added to the Russell 3000 Index 50375 3
...ned Alone and in Combination with Chemotherapy, F...., a,development-stage pharmaceutical company disc...i)-based therapeutics, today announced that the,jo...y of siRNA targeting,its proprietary target gene a...dition dated October 1, 2008. The paper, entitled ...
...Prophylaxis Treatment with Kogenate FS Reduces the...ren with No Pre-Existing,Joint Damage, BERKELEY, ...day that the U.S. Food and Drug Administration (FD...R) FS Antihemophilic Factor,(Recombinant) to reduc...of,joint damage in patients aged 0-16 years with s...
Other Medicine Technology:Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: